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Case Report
Metastatic Esophageal Squamous Cell Carcinoma to the 
Orbit and Periorbit Masquerading as Periorbital Abscess 
Ja Young Lee, Hyun Joon Lee, Moon Sun Jung, So Young Kim
Department of Ophthalmology, Soonchunhyang University Cheonan Hospital, 
Soonchunhyang University College of Medicine, Cheonan, Korea
A 61-year-old man with no history of malignancy presented with a rapidly expanding left periorbital mass, first noticed 
one month prior to presentation. The mass was firm, and a pus-like discharge drained spontaneously from the center 
of the lesion. A biopsy was performed, and histopathology confirmed squamous cell carcinoma. Systemic evaluation 
revealed that the patient had a primary esophageal squamous cell carcinoma with multiple metastases. The prog-
nosis of orbital metastasis is generally poor, and this patient expired after one month of conservative treatment. 
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Metastatic neoplasms of the orbit and periorbit are very 
rare, estimated to account for 1-13% of all reported orbital tu-
mors [1]. A literature search revealed that there have been on-
ly four reported cases of orbital metastasis from esophageal 
tumors [2-5]. In two of these cases, the metastases originated 
from squamous cell carcinomas of the esophagus, and in the 
others, the metastases originated from esophageal adeno- 
carcinomas. If such tumors grow rapidly, they may undergo 
necrosis, as the rate of tumor angiogenesis cannot keep pace 
with the rapidly expanding mass. Here, we report a rare case 
of an orbital metastasis from a squamous cell carcinoma of 
the esophagus, mimicking a periorbital abscess in a patient 
with no previously known history of malignancy.
Case Report
A 61-year-old man presented with a rapidly expanding left 
periorbital mass which he had first noticed one month prior to 
presentation (Fig. 1). The mass was firm with a pus-like dis-
charge draining spontaneously from its center. The patient 
was ill-appearing and complained of dyspepsia and weight 
loss. He also complained of ocular pain and headaches. His past 
medical history was otherwise unremarkable. He was admitted 
for evaluation and treatment. His vision was 6/12 in both eyes; 
the intraocular pressures were 22 mmHg in the right eye and 
30 mmHg in the left eye. Slit lamp examination revealed 
marked chemosis and injection of the left eye. There was no 
diplopia or limitation in duction. An orbital CT scan revealed a 
well-defined 4.2 cm×3.5 cm lesion in the left orbital and peri-
orbital areas. There was no evidence of bone erosion (Fig. 2). 
Biopsies of the mass and conjunctiva were consistent with 
squamous cell carcinoma (Fig. 3). We referred the patient to 
the Department of Hemato-oncology, where a systemic 
workup revealed a primary esophageal carcinoma, a trache-
oesophageal fistula, a lung metastasis, and a right adrenal 
gland metastasis (Fig. 4). The patient was treated con-
servatively, but he expired after one month of treatment. 
Discussion
In contrast to intraocular metastases, orbital metastases are a 
rare manifestation of systemic malignancies; such orbital 
metastases account for only 1-13% of all orbital tumors [1]. 
However, the precise incidence of these lesions is difficult to 
estimate. The incidence of orbital metastases has increased in 
recent years because improvements in treatment modalities 
and diagnostic tools have resulted in improved survival in 
cancer patients. Occult cases have been reported: autopsy re-
ports have revealed that 10-30% of breast cancer patients de-
velop detectable ocular and orbital metastases [6]. 
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Fig. 1. External photograph at the initial examination. The left periorbital mass was firm, and drainage was noted at the center of the lesion.
A  B
Fig. 2. Orbital CT findings. A 4.2 cm x 3.5 cm-sized lesion was seen in the left periorbital area (blue arrows). The lesion was extended from 
the extraconal space to the intraconal space, and compressed the globe. (A) Axial view. (B) Coronal view.
A  B
Fig. 3. Post-enhancement chest and abdominal CT findings. (A) An enhanced mass lesion was identified in the middle esophagus (white ar-
row), and narrowing was noted in the bronchus intermedius. (B) A small nodular lesion was identified in the right adrenal gland (blue arrow).JY Lee, et al. Orbital Metastasis of Esophageal SCC
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Fig. 4. (A) Histologic findings in the left periorbital biopsy specimen. Infiltration of undifferentiated malignant cells suggested the presence 
of squamous cell carcinoma (H & E, ×200). (B) Histologic examination of the left conjunctiva revealed focal nests of atypical cells suspicious 
for carcinoma (blue arrow) (H & E, ×200).
breast, and prostate being the most common primary sites 
[7]. Gastrointestinal carcinomas are the source of 6-7% of all 
orbital metastases. The majority of these carcinomas arise in 
the stomach, ileum, or colon. Our literature search revealed 
only four reported cases of orbital metastases originating 
from esophageal tumors [8,9]. Orbital metastases usually oc-
cur during the advanced stage of cancer, although there is no 
known history of cancer in 19-25% of patients. Ophthalmologic 
symptoms may be preceded by systemic symptoms, espe-
cially if the primary site is the lung, gastrointestinal tract, thy-
roid, or kidney [2,10].
The most common manifestations of orbital metastases are 
diplopia, exophthalmos, inflammation, decreased visual acui-
ty, pain, chemosis, and eyelid swelling, depending on the site 
affected. The symptoms usually occur acutely and progress 
rapidly, over the course of weeks to months [2,9].
The aim in treating orbital metastases is to relieve disc- 
omfort. Surgical removal of the mass is not recommended. 
Regardless of the primary tumor type, prognosis is poor, be-
cause patients with orbital metastases are usually at an ad-
vanced stage of the disease. In one report, the mean survival 
time was 7.4 months. In another report [11], the median surviv-
al time was 1.3 years, and the two-year survival rate is 27%. 
The survival duration was not significantly different among 
patients with different types of primary neoplasms [12]. 
In our patient, ocular symptoms were the initial manifes-
tation of an unknown primary carcinoma. The rapid growth 
of the metastatic cancer led to tumor necrosis and the clinical 
appearance of a periorbital abscess. Prompt surgical biopsy 
enabled confirmation of a squamous cell carcinoma, and sub-
sequent systemic evaluation revealed primary esophageal 
squamous cell carcinoma with multiple metastases. Orbital 
and periorbital metastases can present atypically, and clini-
cians should be cognizant of this fact so that patients can be 
diagnosed in a timely manner. Biopsy is needed to confirm 
the diagnosis. 
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